Browsing Tag
infectious disease therapeutics
1 post
Does host-pathway targeting offer a durable COVID-19 strategy for Bioxytran, Inc.?
Bioxytran, Inc. reports early ProLectin-M data. Explore what host-targeted antivirals mean for COVID-19 strategy and biotech investors.